Envista Holdings Corporation
NVSTHealthcareNASDAQMedical Instruments & Supplies
Headquartered within the healthcare sector, Envista Holdings Corporation focuses on Medical Instruments & Supplies services and products. Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The $4.35B market capitalization puts NVST squarely in mid-cap range for its industry. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.
Market Cap
$4.35B
Beta
0.86
P/E (TTM)
65.22
P/E (Fwd)
17.00
EPS (TTM)
$0.41
EPS (Fwd)
$1.57
ROE
2.2%
ROA
3.0%
Cash
$1.08B
Total Debt
$1.59B
Free CF
$216.3M
52W Change
37.1%
Annual Financials
Cash vs Debt
On the balance sheet, NVST has $1.08B in cash with $1.59B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $216.3M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 2.2%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.0% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $2.57B (2022) to $2.72B (2025).
At over 50x earnings, NVST carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Envista Holdings Corporation and its sector.